SEC 13F Intelligence

Global Imc LLC / ADPT

Global Imc LLC’s Adaptive Biotechnologies Cor Position

Does Global Imc LLC own Adaptive Biotechnologies Cor (ADPT)? Not currently — the last reported position was 409.4K shares worth $5M in Q2 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$5M
Q2 2025
Shares
409.4K
% of Portfolio
+1.24%
Quarters Held
1
position exited

Position History ADPT

Reported value by quarter
Q2 ’25: $5MQ2 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q2 2025409.4K$5M+1.24%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Global Imc LLC’s full portfolio or all institutional holders of ADPT.